Jan 31 (Reuters) - (All figures in Danish Crowns)
* Novozymes A/S NZYMb.CO reports its fourth
quarter results on
February 1.
* Year to date, Novozymes A/S shares are down 2.61%.
* Below is a table of quarterly and annual analyst estimates
for
results based on LSEG data.
Qtr. to No. of Mean Estimate
December analysts
2023
Revenue 7 4.61 billion
EPS
4 2.91
EBITDA 5
1.42 billion
EBIT 5
1.09 billion
Net Profit 5 805.40 million
Year to No. of Mean Estimate
December Analysts
2023
Revenue 13 17.94 billion
Pre-tax 11 4.14 billion
profit
EPS 13 11.86
EBITDA 13
5.85 billion
EBIT 13 4.37 billion
Net Profit 12 3.37 billion
Dividend 12
5.96
Net Debt 8
5.595 million
Novozymes A/S belongs to the OMX Copenhagen 20 Index.
Please note that consensus estimates may be updated between
publication of the poll and the report.
This summary was auto generated on January 30 at 07:36.
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))